Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Hoechst 33258: Advanced DNA Staining for Tumor Microenvironm
2026-07-01
Explore how Hoechst 33258, a bis-benzimide DNA stain, empowers high-resolution analysis of DNA in live and fixed cells, with unique insights into tumor microenvironment research. This article offers a deep dive into assay optimization and pH-linked cell viability, bridging cutting-edge findings with practical workflows.
-
Perphenazine in Dopamine Antagonism and Host Immunity Resear
2026-07-01
Explore how Perphenazine, a dopamine D2 receptor antagonist, uniquely bridges neuropharmacology and host-directed antibacterial research. This article delivers advanced protocol insights and comparative analysis unavailable elsewhere.
-
Dextran Sulfate Sodium Salt (MW 35000-45000) in Colitis Mode
2026-06-30
Dextran sulfate sodium salt (MW 35000-45000) is a validated chemical inducer of experimental colitis, enabling reproducible modeling of ulcerative colitis in mice. This dossier details its mechanism, protocol parameters, and benchmarking evidence for intestinal inflammation research.
-
Geneticin (G-418 Sulfate): Deep Mechanisms and Next-Gen Sele
2026-06-30
Explore the molecular mechanisms and advanced uses of Geneticin (G418 Sulfate) as both a selection antibiotic and antiviral tool. This article uncovers the ribosomal inhibition pathway, practical assay design, and the latest insights for genetic engineering and virology researchers.
-
FGFR3 Inhibition Ameliorates SLC26A2-Related Chondrodysplasi
2026-06-29
This study provides genetic and pharmacological evidence that targeting FGFR3 signaling with the selective inhibitor NVP-BGJ398 phosphate improves chondrodysplasia phenotypes in SLC26A2-deficient mouse models. The findings highlight a promising therapeutic strategy for rare skeletal disorders, with translational implications for FGFR pathway modulation.
-
WSP-5 in Disease Pathophysiology: Precision H2S Imaging Unve
2026-06-29
Explore how WSP-5 (Washington State Probe-5) enables ultra-sensitive, real-time detection of hydrogen sulfide in complex biological systems, with a unique focus on mechanistic insights linking H2S imaging to disease pathogenesis. This article bridges advanced probe chemistry with practical assay decisions for innovative research.
-
Elobixibat hydrate (SKU C8720): Reliable IBAT Inhibitor for
2026-06-28
This article addresses key experimental challenges in gastrointestinal and metabolic research, detailing how Elobixibat hydrate (SKU C8720) offers reproducibility and validated performance for cell-based assays and translational protocols. Drawing on practical scenarios, the discussion guides biomedical researchers in leveraging this selective IBAT inhibitor for robust data and workflow efficiency.
-
Dimethyloxalylglycine (DMOG): Technical Guide for Hypoxia Mo
2026-06-27
Dimethyloxalylglycine (DMOG) is a cell-permeable PHD inhibitor used to stabilize hypoxia-inducible factor (HIF-1α), enabling researchers to mimic hypoxic conditions in vitro and in vivo. It is appropriate for studies of hypoxia signaling, inflammation, and immune modulation but is not suitable for diagnostic or medical applications. Proper handling and precise protocol adherence are essential for reproducibility.
-
Targeted Peptide Nanocarriers Enhance Breast Cancer Therapy
2026-06-26
This study introduces a targeted, acid-sensitive peptide nanocarrier (DT/Pep1) for delivering doxorubicin and triptolide to breast cancer cells. By improving tumor targeting, inducing immunogenic cell death, and modulating the tumor immune environment, the research offers a promising direction for enhancing the efficacy and specificity of cancer therapy.
-
BAPTA in Environmental Toxicology: Unraveling Calcium-Driven
2026-06-26
Explore how BAPTA, a high-affinity calcium chelator, advances mechanistic insight into calcium-dependent apoptosis, especially in the context of nanoplastics and cadmium co-exposure. This in-depth article reveals unique assay strategies and translational impact beyond standard cell signaling studies.
-
WSP-5: Advanced Live-Cell Imaging of Hydrogen Sulfide Dynami
2026-06-25
WSP-5 (Washington State Probe-5) redefines live-cell hydrogen sulfide imaging with rapid activation and exceptional selectivity, enabling precise tracking of endogenous and exogenous H2S in disease models. Its workflow adaptability and superior sensitivity empower researchers to unravel intricate H2S-mediated pathways in cardiovascular and cancer biology.
-
CTP Solution (100 mM): Precision for mRNA-LNP and RNA Synthe
2026-06-25
CTP Solution (100 mM) delivers the nucleotide purity and contaminant-free assurance required for cutting-edge in vitro transcription and mRNA-LNP therapeutics. This guide translates recent landmark bladder cancer research into actionable protocols, troubleshooting strategies, and competitive workflow advantages for translational and molecular biology labs.
-
Neomycin sulfate (SKU B1795): Reliable Solutions for Molecul
2026-06-24
Discover how Neomycin sulfate (SKU B1795), an aminoglycoside antibiotic, addresses persistent challenges in molecular biology assays, from RNA/DNA structure studies to ion channel research. This scenario-driven article provides evidence-based guidance and protocol insights, empowering researchers to achieve reproducible, high-sensitivity results.
-
P2Y11 Antagonist NF 340: Precision Tools for GPCR Signaling
2026-06-23
NF 340 stands out as a selective P2Y11 antagonist, enabling researchers to dissect purinergic signaling with confidence. Its proven efficacy in modulating inflammation and cancer cell invasiveness gives immunology and oncology labs a powerful, reproducible edge.
-
Iron Stress Alters Enterocyte Metabolism and Inflammatory Re
2026-06-23
Navazesh and Ji's 2025 study provides a detailed analysis of how iron deficiency and excess reprogram metabolic and inflammatory pathways in IPEC-J2 enterocytes. Their findings clarify the cellular consequences of iron imbalance and inform future research on intestinal health, iron chelation, and disease modeling.